Product Name: Human IGF1R / CD221 Antibody (Immunomedics patent anti-IGF-1R, Research Use)
Catalog Number: NBR-0681
Target Name: IGF1R / CD221
Trade Name: Immunomedics patent anti-IGF-1R
Antibody Drug Description: The drug is a recombinant fully human anti-IGF-1R monoclonal antibody, being developed by Immunomedics. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IGF1R
Synonyms: CD221; IGFIR; IGFR; JTK13; MGC18216
Target Description: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. 
Ensembl: ENSG00000140443
Uniprot: P08069